Touch Bionics introduces i-limb quantum bionic hand at ISPO Congress

NewsGuard 100/100 Score

i-limb quantum introduces ground-breaking new standard for myoelectric prosthetic hands

Touch Bionics, a provider of world-leading prosthetic technologies, today announced a significant addition to the company's i-limb™ range of bionic hands at the International Society of Prosthetics & Orthotics (ISPO) World Congress taking place in Lyon, France. The i-limb quantum incorporates the company's patented i-mo™ technology and is the first upper limb prosthesis that can change grips with a simple gesture.

"We are pleased to introduce the i-limb quantum at the ISPO Congress," said Ian Stevens, CEO of Touch Bionics. "The new hand combines unsurpassed functionality with design style. It is smarter, faster, stronger and smaller than any of its predecessors. i-limb wearers can quickly utilise the many grips available through the activation of gesture control using i-mo technology embedded in every i-limb quantum."

"The i-limb quantum is the most advanced prosthesis available for individuals affected by limb differences," said Rebekah Marine, i-limb wearer. "I particularly appreciate the ability to almost effortlessly choose different grips using subtle but distinct gestures. The new extra small size will appeal in particular to female users and children."

i-limb quantum - key enhancements:

  • Smarter - i-mo technology uses simple gestures to change grips
  • Faster - boost digit speed by up to 30%
  • Stronger - up to 30% more power when needed
  • Smaller - anatomical styling now available in 3 sizes

Touch Bionics is located at stand B06. Live product demonstrations with i-limb users and staff experts will be held throughout the ISPO exhibit hours.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revolutionizing diabetes management with reliable blood glucose monitoring without finger pricking